TOPIC

Biomedicine: Policy

Related Topics:
Biomedicine: Companies
Biomedicine: Policy
Biomedicine: Science
Biomedicine: Industry Trends
Biomedicine: Geopolitics
Biomedicine: Policy
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
The value of Chinese biotech development deals, mostly out-licensing, rose 68 per cent year on year in the first nine months of last year to US$36.6 billion. Photo: Shutterstock
Biomedicine: Companies

Chinese biotech firms cash in on promising drug discoveries via licensing

China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.

videocam
Artificial intelligence

China’s tech push: Shanghai aims to be global medical AI hub by 2027

Biomedicine: Companies

Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds

Biomedicine: Companies

China welcomes new US$1 billion Sanofi project in Beijing

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi said the new plant in Beijing will be its fourth such facility on the mainland. Photo: Shutterstock
Health & Fitness

China expands health insurance coverage with 91 new drugs, innovative treatments

The health authority shows its support for novel drugs, while driving tough bargains with pharmaceutical firms on prices.

videocam
Biomedicine: Companies

Chinese biotech firms brace for Trump tariffs, US funding bill

Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.

Advertisement
Advertisement
Advertisement
Shenzhen

Shenzhen’s soaring R&D spending rivals Beijing, dwarfs Hong Kong

The southern city put nearly US$31 billion into R&D last year, driven partly by robust spending from tech giants like Huawei.

Shenzhen is China’s second-largest R&D hub by expenditure. Photo: Costfoto/NurPhoto via Getty Images
Greater Bay Area

Hong Kong health-tech start-ups create digital wearables for seniors

With a regulatory approach that expands the market for such devices to the Greater Bay Area, local companies see opportunity for growth.

videocam
Shanghai

Shanghai to back local biopharma firms’ overseas push, regulatory compliance

The initiative aims to generate about US$7 billion from medical product exports by 2027.

videocam
Health & Fitness

Ultrasound cancer treatment, supported by Li Ka-shing, gains traction in Asia

Focused ultrasound, backed by Li Ka-shing, is emerging as a non-invasive, commercially viable cancer treatment, attracting significant investments.

videocam
Neal Kassell, a neurosurgeon, is the founder and chairman of US-based Focused Ultrasound Foundation. Photo: Sun Yeung
US-China relations

Opinion | Is biotech the next battleground in US-China decoupling?

With both countries viewing technological leadership as a zero-sum game, the risk of a fragmented global innovation ecosystem is growing.

videocam
Illustration: Craig Stephens
Science

China’s strides in academic research seen to narrow US lead in medical science

Growing momentum in research sets China up as a formidable player in future of global healthcare, according to scientific publishers.

videocam
39
China technology

China eyes sci-tech venture capital to boost industrial upgrade, economic growth

Premier Li Qiang said on Wednesday the development of venture capital is critical to sci-tech innovation, industrial upgrading and the growth of the economy.

Technology

Hong Kong fund inks deal with biotech start-up as city aims for tech hub status

The Hong Kong Investment Corporation has struck a deal with a biotech firm started by Baidu founder Robin Li Yanhong, the fund’s second public move as the city seeks to boost its tech sector.

A view of the signing ceremony for the HKIC and Biomap announcement on Monday. Photo: Facebook/Jesse Shang Hailong
Banking & finance

Hong Kong attracts US$832 million in investment from life-science firms

The investments, which will yield 3,200 jobs, come amid government efforts to enhance Hong Kong’s position as an innovation hub in the field.

The Hong Kong government has created funding incentives to support life sciences firms in every stage of their development from basic research to clinical trials, manufacturing, and marketing, official says. Photo: Shutterstock
Banking & finance

Shanghai’s US$13.8 billion fund of funds to boost AI, semiconductor firms

Mainland China’s commercial and financial hub plans to set up a 100 billion yuan (US$13.8 billion) fund of funds focusing on key technology sectors to fire up the local economy.

Shenzhen

Chinese drugs giant, Shenzhen team up to invest in city’s biomedical start-ups

Fosun Pharma will team up with Shenzhen’s government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular biology, genetics and other fields related to biomedicine.

videocam
Advertisement
Advertisement
Advertisement
Science

As China’s economy undergoes ‘structural upgrade’, tech becomes a top priority

That amounts to US$51.5 billion for 2024, with continued expenditure ‘guaranteed’ because of sector’s key role in driving development.

videocam
50
Science and technology has emerged as a priority area for Beijing. Photo: Shutterstock Images
China economy

Opinion | China tech: Wuxi model shows local governments how to drive growth

Wuxi’s evolution from an industrial hub to an epicentre of technological innovation offers other local governments a prime example of how to employ a unique blend of public and private sector integration to promote regional economic development.

Millionaires and billionaires

China’s healthcare tycoons lose US$17 billion as crackdown spreads

The combined fortune of the top 15 Chinese healthcare billionaires has fallen 17 per cent to US$84.1 billion amid a sweeping anti-corruption campaign that started about two months ago.

Medicine

China targets hi-tech drug and medical equipment industries for support

State Council unveils plans to promote development in the areas over the next two years.

videocam
9
China has come up with plans to support advances in the pharmaceutical and medical equipment industries. Photo: AFP
Science

Stem cell study in Nature didn’t have ethical approval, Chinese academy says

Paperwork was falsified during the process of publishing the research, according to head of CAS ethics committee office.

videocam
China has strengthened ethics oversight on scientific research involving humans in recent years. Illustration: Shutterstock Images
Semiconductors

Shanghai woos semiconductor and AI projects with generous subsidies

New policy is aimed at enhancing ‘vitality of industrial development’ and improving ‘city’s core competitiveness’.

Science

China issues ‘most comprehensive’ bioethics rules since gene-edited baby scandal

Latest rules on life sciences and medical research involving humans expand regulatory scope of 2016 guideline and spell out administrative penalties.

videocam
Shenzhen

Shenzhen’s hi-tech goals for 2025 defy US hostility and slowing growth

China’s southern tech hub of Shenzhen aims for 40 per cent growth over five years, with the goal of becoming an international hub of innovation, despite challenges from the US for local tech giants.

Home to tech giants like Tencent, DJI, Huawei and ZTE, Shenzhen has come to be known as China’s Silicon Valley. Photo: Xinhua
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement